Reversibility of the anticoagulant effect of high doses of the direct thrombin inhibitor dabigatran, by recombinant factor VIIa or activated prothrombin complex concentrate - van Ryn, J; Ruehl, D; Priepke, H; Hauel, N; Wienen, W
Haematologica 2008;93(Suppl 1)